283 related articles for article (PubMed ID: 36396497)
1. Mitochondrial quality control mechanisms as therapeutic targets in doxorubicin-induced cardiotoxicity.
Wu L; Wang L; Du Y; Zhang Y; Ren J
Trends Pharmacol Sci; 2023 Jan; 44(1):34-49. PubMed ID: 36396497
[TBL] [Abstract][Full Text] [Related]
2. Doxorubicin-induced cardiomyocyte death is mediated by unchecked mitochondrial fission and mitophagy.
Catanzaro MP; Weiner A; Kaminaris A; Li C; Cai F; Zhao F; Kobayashi S; Kobayashi T; Huang Y; Sesaki H; Liang Q
FASEB J; 2019 Oct; 33(10):11096-11108. PubMed ID: 31291545
[TBL] [Abstract][Full Text] [Related]
3. SESN2 protects against doxorubicin-induced cardiomyopathy via rescuing mitophagy and improving mitochondrial function.
Wang P; Wang L; Lu J; Hu Y; Wang Q; Li Z; Cai S; Liang L; Guo K; Xie J; Wang J; Lan R; Shen J; Liu P
J Mol Cell Cardiol; 2019 Aug; 133():125-137. PubMed ID: 31199952
[TBL] [Abstract][Full Text] [Related]
4. Role of mitochondria in doxorubicin-mediated cardiotoxicity: From molecular mechanisms to therapeutic strategies.
Wang T; Xing G; Fu T; Ma Y; Wang Q; Zhang S; Chang X; Tong Y
Cell Stress Chaperones; 2024 Apr; 29(2):349-357. PubMed ID: 38485043
[TBL] [Abstract][Full Text] [Related]
5. Cardioprotective effects of melatonin and metformin against doxorubicin-induced cardiotoxicity in rats are through preserving mitochondrial function and dynamics.
Arinno A; Maneechote C; Khuanjing T; Ongnok B; Prathumsap N; Chunchai T; Arunsak B; Kerdphoo S; Shinlapawittayatorn K; Chattipakorn SC; Chattipakorn N
Biochem Pharmacol; 2021 Oct; 192():114743. PubMed ID: 34453902
[TBL] [Abstract][Full Text] [Related]
6. Sphingosylphosphorylcholine ameliorates doxorubicin-induced cardiotoxicity in zebrafish and H9c2 cells by reducing excessive mitophagy and mitochondrial dysfunction.
Zhou J; Lu Y; Li Z; Wang Z; Kong W; Zhao J
Toxicol Appl Pharmacol; 2022 Oct; 452():116207. PubMed ID: 35995203
[TBL] [Abstract][Full Text] [Related]
7. Mitophagy inhibitor liensinine suppresses doxorubicin-induced cardiotoxicity through inhibition of Drp1-mediated maladaptive mitochondrial fission.
Liang X; Wang S; Wang L; Ceylan AF; Ren J; Zhang Y
Pharmacol Res; 2020 Jul; 157():104846. PubMed ID: 32339784
[TBL] [Abstract][Full Text] [Related]
8. Autophagy and mitophagy in the context of doxorubicin-induced cardiotoxicity.
Koleini N; Kardami E
Oncotarget; 2017 Jul; 8(28):46663-46680. PubMed ID: 28445146
[TBL] [Abstract][Full Text] [Related]
9. Loss of Rubicon ameliorates doxorubicin-induced cardiotoxicity through enhancement of mitochondrial quality.
Liu X; Zhang S; An L; Wu J; Hu X; Lai S; Mazhar H; Zou Y; He L; Zhu H
Int J Cardiol; 2019 Dec; 296():129-135. PubMed ID: 31439425
[TBL] [Abstract][Full Text] [Related]
10. Role of mitochondria in doxorubicin-mediated cardiotoxicity: from molecular mechanisms to therapeutic strategies.
Wang T; Xing G; Fu T; Ma Y; Wang Q; Zhang S; Chang X; Tong Y
Int J Med Sci; 2024; 21(5):809-816. PubMed ID: 38617011
[TBL] [Abstract][Full Text] [Related]
11. Mitochondrial Sirtuins and Doxorubicin-induced Cardiotoxicity.
He L; Liu F; Li J
Cardiovasc Toxicol; 2021 Mar; 21(3):179-191. PubMed ID: 33438065
[TBL] [Abstract][Full Text] [Related]
12. Klotho attenuated Doxorubicin-induced cardiomyopathy by alleviating Dynamin-related protein 1 - mediated mitochondrial dysfunction.
Zhuang X; Sun X; Zhou H; Zhang S; Zhong X; Xu X; Guo Y; Xiong Z; Liu M; Lin Y; Zhang M; Liao X
Mech Ageing Dev; 2021 Apr; 195():111442. PubMed ID: 33539906
[TBL] [Abstract][Full Text] [Related]
13. Dosing depending on SIRT3 activity attenuates doxorubicin-induced cardiotoxicity via elevated tolerance against mitochondrial dysfunction and oxidative stress.
Yang N; Ma H; Jiang Z; Niu L; Zhang X; Liu Y; Wang Y; Cheng S; Deng Y; Qi H; Wang Z
Biochem Biophys Res Commun; 2019 Sep; 517(1):111-117. PubMed ID: 31303273
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of cyclin-dependent kinase 2 protects against doxorubicin-induced cardiomyocyte apoptosis and cardiomyopathy.
Xia P; Liu Y; Chen J; Coates S; Liu DX; Cheng Z
J Biol Chem; 2018 Dec; 293(51):19672-19685. PubMed ID: 30361442
[TBL] [Abstract][Full Text] [Related]
15. Foxo3a inhibits mitochondrial fission and protects against doxorubicin-induced cardiotoxicity by suppressing MIEF2.
Zhou L; Li R; Liu C; Sun T; Htet Aung LH; Chen C; Gao J; Zhao Y; Wang K
Free Radic Biol Med; 2017 Mar; 104():360-370. PubMed ID: 28137654
[TBL] [Abstract][Full Text] [Related]
16. Promoting mitochondrial fusion in doxorubicin-induced cardiotoxicity: a novel therapeutic target for cardioprotection.
Maneechote C; Khuanjing T; Ongnok B; Arinno A; Prathumsap N; Chunchai T; Arunsak B; Nawara W; Chattipakorn SC; Chattipakorn N
Clin Sci (Lond); 2022 Jun; 136(11):841-860. PubMed ID: 35543245
[TBL] [Abstract][Full Text] [Related]
17. Mitochondria-Targeting Small Molecules Effectively Prevent Cardiotoxicity Induced by Doxorubicin.
Shi W; Deng H; Zhang J; Zhang Y; Zhang X; Cui G
Molecules; 2018 Jun; 23(6):. PubMed ID: 29921817
[TBL] [Abstract][Full Text] [Related]
18. Doxorubicin induced cardio toxicity through sirtuins mediated mitochondrial disruption.
Ahmad N; Ullah A; Chu P; Tian W; Tang Z; Sun Z
Chem Biol Interact; 2022 Sep; 365():110028. PubMed ID: 35921947
[TBL] [Abstract][Full Text] [Related]
19. Qishen Granule Protects against Doxorubicin-Induced Cardiotoxicity by Coordinating MDM2-p53-Mediated Mitophagy and Mitochondrial Biogenesis.
Li W; Zhang Y; Wang X; Cao J; Qian W; Ling G; Tan N; Jiang J; Sun Q; Li C; Wang W; Wang Y
Oxid Med Cell Longev; 2022; 2022():4344677. PubMed ID: 36120600
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of Kininogen-1 aggravates oxidative stress and mitochondrial dysfunction in DOX-induced cardiotoxicity.
Cheng X; Liu D; Song H; Tian X; Yan C; Han Y
Biochem Biophys Res Commun; 2021 Apr; 550():142-150. PubMed ID: 33706097
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
